Thursday, February 26, 2009

Sanofi-Aventis leads the race to buy Piramal

French drug major Sanofi-Aventis (SNY) has emerged as the lead bidder to buy a sizeable stake in Piramal Healthcare at over 50% premium to the Indian company`s current share price,
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)